Photo by Matthew Modoono
Periodontal disease, also known as gum disease, is a serious infection that affects nearly 50 percent of Americans aged 30 years and older. If left unchecked, periodontal disease can destroy the jawbone and lead to tooth loss. The disease is also associated with higher risk of diabetes and cardiovascular disease.
The current treatment for periodontal disease involves opening the infected gum flaps and adding bone grafts to strengthen the teeth. But in new research published recently in the journal Frontiers in Immunology, Forsyth Institute scientists have discovered that a specific type of molecule may stimulate stem cells to regenerate, reversing the inflammation caused by periodontal disease. This finding could lead to the development of new therapeutics to treat a variety of systemic diseases that are characterized by inflammation in the body.
For the study, Dr. Alpdogan Kantarci, his PhD student Dr. Emmanuel Albuquerque, and their team removed stem cells from previously extracted wisdom teeth and placed the stem cells onto petri dishes. The researchers then created a simulated inflammatory periodontal disease environment in the petri dishes. Next, they added two specific types of synthetic molecules called Maresin-1 and Resolvin-E1, both specialized pro-resolving lipid mediators from omega-3 fatty acids. The scientists found that Mar1 and RvE1 stimulated the stem cells to regenerate even under the inflammatory conditions.
“Both Maresin-1 and Resolvin-1 reprogrammed the cellular phenotype of the human stem cells, showing that even in response to inflammation, it is possible to boost capacity of the stem cells so they can become regenerative,” said Dr. Kantarci, Associate Member of Staff at the Forsyth Institute.
This finding is important because it allows scientists to identify the specific protein pathways involved in inflammation. Those same protein pathways are consistent across many systemic diseases, including periodontal disease, diabetes, heart disease, dementia, and obesity.
“Now that we understand how these molecules stimulate the differentiation of stem cells in different tissues and reverse inflammation at a critical point in time, the mechanism we identified could one day be used for building complex organs” said Dr. Kantarci. “There is exciting potential for reprogramming stem cells to focus on building tissues.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Biological imbalance link between gum and kidney disease, claim expertson January 25, 2021 at 6:00 am
An imbalance of the body's oxygen producing free radicals and its antioxidant cells could be the reason why gum disease and chronic kidney disease affect each other, a new study led by ...
- Dental Laboratories Market: High Prevalence of Dental Diseases to Bolster its Demand in the Marketon January 24, 2021 at 10:20 pm
The market for dental laboratories is anticipated to experience a tremendous growth in coming years due to rise in prevalence of periodontal diseases. One ...
- Holloway gives update on Fall 2021 semester planning, Rutgers coronavirus vaccine effortson January 24, 2021 at 9:18 pm
University President Jonathan Holloway sent an email to the Rutgers community on Friday to provide his monthly update on University operations amid the coronavirus disease (COVID-19) pandemic.
- ANDY BRACK: DHEC has trouble walking, chewing gum in pandemicon January 22, 2021 at 9:30 pm
The South Carolina Department of Health and Environmental Control isn’t exactly a confidence-inspiring agency.
- Dental Implants Market: Growing Preference for Dental Implants over Dental Procedures to Boost Market Growthon January 22, 2021 at 6:34 am
Transparency Market Research (TMR) has published a new report titled, ‘Dental Implants Market - Global Industry Analysis, Size, Share, Growth, Trends, and ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Stem cell stimulation
- Therapeutic Solutions International Reports Regression of Glioma, Lung Cancer and Colorectal Cancer using StemVacs in Animal Modelson January 25, 2021 at 6:30 am
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today expansion of its preclinical dataset on StemVacs, an ...
- Pulse Biosciences Announces CE Mark Approval for CellFX® Systemon January 25, 2021 at 5:00 am
We are excited about this major milestone for Pulse Biosciences which keeps us on track to commercialize the CellFX System in the EU this quarter. The CE mark is the first commercial regulatory ...
- Personalized Skin Cancer Vaccine Appears Effective In Clinical Trialon January 25, 2021 at 3:12 am
A four-year-long Phase 1 trial of a personalized skin cancer vaccine has concluded and shows that the vaccine has huge promise in fighting off melanoma ove ...
- Big Differences in Long-Term Immunity Resulting From Mild vs. Severe COVID-19 Caseson January 24, 2021 at 4:36 am
New research highlights the enormous variability in how T cells respond to the deadly virus. A big question on people's minds these days: how long does immunity to SARS-CoV-2 last following infection?
- Study sheds light on role played by immune system's T-cells against coronaviruson January 22, 2021 at 1:25 am
In particular, they said memory CD8 T cells are important for protecting the body from reinfection against many viruses.